Koji Yoshino Selected Research

C-Reactive Protein

10/2019	Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
8/2019	Dynamics of neutrophil and C-reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Yoshino Research Topics

Disease

28	Melanoma (Melanoma, Malignant) 07/2023 - 06/2016
15	Neoplasms (Cancer) 11/2023 - 01/2010
6	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2017
4	Hemangiosarcoma (Angiosarcoma) 11/2023 - 01/2017
4	Extramammary Paget Disease (Paget Disease, Extramammary) 11/2022 - 06/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 01/2019
3	Disease Progression 10/2019 - 01/2018
3	Fever (Fevers) 08/2019 - 06/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2023 - 01/2018
2	Hemorrhage 12/2018 - 01/2010
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2017
2	Massive Hepatic Necrosis 01/2017 - 01/2017
2	Hepatitis 01/2017 - 01/2017
1	Myocarditis (Carditis) 01/2024
1	Skin Neoplasms (Skin Cancer) 11/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2022
1	Frailty 03/2022
1	Diarrhea 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Pancytopenia 06/2020
1	Colitis 10/2019
1	Clear Cell Sarcoma 08/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2018
1	Ileus 12/2018
1	Orthostatic Hypotension (Postural Hypotension) 12/2018
1	Infections 12/2018
1	Surgical Wound 12/2018
1	Margins of Excision 12/2018
1	Aspiration Pneumonia 12/2018
1	Delirium 12/2018
1	Residual Neoplasm 01/2018
1	Exanthema (Rash) 05/2017
1	Fatigue 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Dermatitis 01/2017
1	Pancreatitis 01/2017
1	Thyroiditis 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Anemia 01/2017
1	Myalgia 06/2016
1	Hypothyroidism 06/2016
1	Hyperthyroidism 06/2016
1	Breast Neoplasms (Breast Cancer) 01/2010

Drug/Important Bio-Agent (IBA)

17	NivolumabIBA 01/2023 - 06/2016
7	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
7	IpilimumabIBA 01/2023 - 11/2017
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
4	AntibodiesIBA 08/2022 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 02/2023
2	taxaneIBA 07/2023 - 02/2023
2	Docetaxel (Taxotere)FDA Link 02/2023 - 06/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2021
2	dabrafenibIBA 12/2021 - 08/2019
2	trametinibIBA 12/2021 - 08/2019
2	C-Reactive ProteinIBA 10/2019 - 08/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
2	pembrolizumabIBA 03/2018 - 01/2018
2	VemurafenibIBA 05/2017 - 01/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2024
1	Methylprednisolone FDA LinkGeneric 01/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2024
1	TroponinIBA 01/2024
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2023
1	Plasminogen Activator Inhibitor 1IBA 11/2023
1	DDTIBA 02/2023
1	5-((glucopyranosyloxy)methyl)uracilIBA 09/2022
1	encorafenibIBA 03/2021
1	binimetinibIBA 03/2021
1	Insulin-Like PeptidesIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 08/2019
1	Prednisolone (Predate)FDA LinkGeneric 08/2019
1	PlatinumIBA 03/2019
1	LigandsIBA 10/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2018
1	human ERBB2 proteinIBA 05/2018
1	eribulin FDA Link 01/2018
1	TrabectedinIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	Therapeutic UsesIBA 01/2017
1	pazopanib FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Monoclonal AntibodiesIBA 06/2016
1	Fixatives (Pickling Agents)IBA 01/2010

Therapy/Procedure

25	Therapeutics 11/2023 - 01/2017
4	Immunotherapy 01/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 03/2019 - 06/2016
3	Chemoradiotherapy 02/2023 - 01/2018
2	Skin Transplantation (Skin Grafting) 01/2019 - 12/2018
2	Early Ambulation 01/2019 - 12/2018
1	Polypharmacy 03/2022
1	Bed Rest (Bedrest) 01/2019
1	Neoadjuvant Therapy 01/2018
1	Salvage Therapy 01/2018
1	Maintenance Chemotherapy 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2016